- Home
- WYNN vs NBIX Comparison
WYNN vs NBIX Comparison
Compare WYNN & NBIX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- WYNN
- NBIX
- Stock Information
- Founded
- WYNN 2002
- NBIX 1992
- Country
- WYNN United States
- NBIX United States
- Employees
- WYNN N/A
- NBIX 1448
- Industry
- WYNN Hotels/Resorts
- NBIX Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- WYNN Consumer Discretionary
- NBIX Health Care
- Exchange
- WYNN Nasdaq
- NBIX Nasdaq
- Market Cap
- WYNN 9.9B
- NBIX 11.8B
- IPO Year
- WYNN 2002
- NBIX 1996
- Fundamental
- Price
- WYNN $90.74
- NBIX $117.44
- Analyst Decision
- WYNN Strong Buy
- NBIX Buy
- Analyst Count
- WYNN 13
- NBIX 24
- Target Price
- WYNN $117.15
- NBIX $163.91
- AVG Volume (30 Days)
- WYNN 3.1M
- NBIX 1.0M
- Earning Date
- WYNN 11-04-2024
- NBIX 10-30-2024
- Dividend Yield
- WYNN 1.10%
- NBIX N/A
- EPS Growth
- WYNN 2755.61
- NBIX 97.40
- EPS
- WYNN 8.43
- NBIX 3.73
- Revenue
- WYNN $7,129,624,000.00
- NBIX $2,242,800,000.00
- Revenue This Year
- WYNN $10.86
- NBIX $26.97
- Revenue Next Year
- WYNN $2.25
- NBIX $16.69
- P/E Ratio
- WYNN $10.77
- NBIX $31.50
- Revenue Growth
- WYNN 25.16
- NBIX 25.72
- 52 Week Low
- WYNN $71.63
- NBIX $108.14
- 52 Week High
- WYNN $110.38
- NBIX $157.98
- Technical
- Relative Strength Index (RSI)
- WYNN 47.56
- NBIX 42.69
- Support Level
- WYNN $84.54
- NBIX $119.08
- Resistance Level
- WYNN $95.20
- NBIX $129.67
- Average True Range (ATR)
- WYNN 2.99
- NBIX 3.34
- MACD
- WYNN -0.52
- NBIX -0.02
- Stochastic Oscillator
- WYNN 40.21
- NBIX 14.59
About WYNN Wynn Resorts Limited Common stock
Wynn Resorts operates luxury casinos and resorts. The company was founded in 2002 by Steve Wynn, the former CEO. The company operates four megaresorts: Wynn Macau and Encore in Macao and Wynn Las Vegas and Encore in Las Vegas. Cotai Palace opened in August 2016 in Macao, and Encore Boston Harbor in Massachusetts opened June 2019. We expect the company to continue to build nongaming attractions in Macao over the next few years. We model Wynn's managed integrated resort in the United Arab Emirates to open in 2027. The company also operates Wynn Interactive, a digital sports betting and iGaming platform. The company received 76% and 24% of its 2019 prepandemic EBITDA from Macao and the US, respectively.
About NBIX Neurocrine Biosciences Inc.
Neurocrine Biosciences Inc is a research-based pharmaceutical company advancing drug candidates in the central nervous system and endocrine-related categories. The company's three late stage clinical programs are elagolix which is hormone releasing antagonist for women's health, opicapone which is an inhibitor for parkinson's patients, and ingrezza for tourette syndrome.